Variable

Overall

Men

Women

p-value

Number

176

113

63

-

Mean age ± SD

49.06 ± 13.97

50.69 ± 13.89

46.15 ± 13.73

0.054

Monthly income < 35000 n (%)

89 (50.57)

38 (33.63)

51 (80.95)

<0.001

Arterio-venous fistula n (%)

165 (93.75)

103 (91.15)

62 (98.41)

0.100

Mean duration on dialysis (months)

26.5

26

27

1.000

Two weekly sessions n %

171 (97.16)

110 (97.35)

61 (96.83)

1.000

Comorbidities

Hypertensionn (%)

HTN mean duration ± SD (years)

HTN treatment n (%)

HTN with regular treatment n (%)

158 (89.77)

9.09 ± 6.62

137(86.71%)

64 (46.72%)

103 (91.15)

8.91 ± 6.64

-

-

55 (87.30)

9.44 ± 6.62

-

-

0.444

0.624

-

-

Diabetes n (%)

34 (19.32)

30 (26.55)

4 (6.35)

0.001

Left ventricular hypertrophy n (%)

96 (54.55)

57 (50.44)

39 (61.90)

0.158

HIV n (%)

13 (7.39)

4 (3.54)

9 (14.29)

0.014

Gout n (%)

10 (5.68)

9 (7.96)

1 (1.59)

0.098

Use of ESA n (%)

42 (23.86)

29 (25.66)

13 (20.63)

0.580

Use of calcium n (%)

131 (74.43)

86 (76.11)

45 (71.43)

0.589

Background nephropathy n (%)

Nephroangiosclerosis

Diabetes Nephropathy

HIV

Chronic glomerulonephritis

Chronic interstitial nephritis

Polycystic kidney disease

Unknown

29 (16.48)

25 (14.20)

10 (5.68)

43 (24.43)

9 (5.11)

2 (1.14)

58 (32.95)

23 (20.35)

21 (18.58)

4 (3.54)

28 (24.78)

5 (4.42)

0 (0.00)

32 (28.32)

6 (9.52)

4 (6.35)

6 (9.52)

15 (23.81)

4 (6.35)

2 (3.17)

26 (41.27)

0.089

0.026

0.170

1.000

0.723

0.127

0.095